Thermo Fisher Scientific, Inc. Stock
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 504.82 USD | -0.98% |
|
-7.00% | -12.88% |
| Capitalization | 190B 160B 146B 139B 258B 17,178B 268B 1,695B 673B 8,296B 711B 697B 28,994B | P/E ratio 2025 |
32.7x | P/E ratio 2026 * | 25.8x |
|---|---|---|---|---|---|
| Enterprise value | 218B 184B 168B 160B 297B 19,740B 308B 1,948B 773B 9,533B 817B 801B 33,318B | EV / Sales 2025 |
5.55x | EV / Sales 2026 * | 4.6x |
| Free-Float |
86.06% | Yield 2025 * |
0.33% | Yield 2026 * | 0.36% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | -0.98% | ||
| 1 week | -7.00% | ||
| Current month | -12.75% | ||
| 1 month | -18.82% | ||
| 3 months | -12.77% | ||
| 6 months | +4.08% | ||
| Current year | -12.88% |
| 1 week | 493.64 | 550.95 | |
| 1 month | 493.64 | 643.99 | |
| Current year | 493.64 | 643.99 | |
| 1 year | 385.46 | 643.99 | |
| 3 years | 385.46 | 643.99 | |
| 5 years | 385.46 | 672.34 | |
| 10 years | 126.42 | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 58 | 15/10/2009 |
| Director of Finance/CFO | 59 | 01/08/2015 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 68 | 09/11/2006 |
Marc Casper
CHM | Chairman | 58 | 26/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 65 | 26/05/2009 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.98% | -7.00% | -5.08% | -11.66% | 190B | ||
| +1.51% | -0.47% | -18.42% | +101.52% | 173B | ||
| -1.10% | -1.86% | +3.04% | -17.04% | 150B | ||
| +0.82% | -2.02% | -29.57% | +58.06% | 111B | ||
| +0.79% | -1.74% | -29.86% | -20.76% | 53.87B | ||
| -0.75% | -3.61% | -0.42% | -0.94% | 44.03B | ||
| +2.78% | -7.02% | +8.40% | +18.06% | 36.79B | ||
| +2.15% | -0.38% | -12.87% | +10.65% | 36.61B | ||
| +0.74% | -2.91% | -6.58% | -17.79% | 35.58B | ||
| -1.19% | -1.96% | -25.99% | -42.05% | 32.52B | ||
| Average | +0.48% | -2.48% | -11.74% | +7.80% | 86.27B | |
| Weighted average by Cap. | +0.21% | -2.46% | -11.40% | +19.79% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 44.28B 37.31B 34.03B 32.49B 60.3B 4,010B 62.66B 396B 157B 1,937B 166B 163B 6,768B | 46.82B 39.45B 35.98B 34.35B 63.77B 4,241B 66.25B 419B 166B 2,048B 176B 172B 7,157B |
| Net income | 6.72B 5.67B 5.17B 4.93B 9.16B 609B 9.52B 60.11B 23.86B 294B 25.22B 24.7B 1,028B | 7.36B 6.2B 5.66B 5.4B 10.02B 667B 10.41B 65.79B 26.12B 322B 27.6B 27.03B 1,125B |
| Net Debt | 28.29B 23.83B 21.74B 20.75B 38.53B 2,562B 40.03B 253B 100B 1,237B 106B 104B 4,324B | 25.48B 21.47B 19.58B 18.7B 34.71B 2,308B 36.06B 228B 90.43B 1,115B 95.56B 93.6B 3,895B |
Employees
125,000
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 504.82 $ | -0.98% | 3,188,361 |
| 12/02/26 | 509.82 $ | -3.29% | 4,742,103 |
| 11/02/26 | 527.17 $ | -2.34% | 3,367,617 |
| 10/02/26 | 539.80 $ | -1.27% | 2,022,058 |
| 09/02/26 | 546.76 $ | +0.72% | 2,107,617 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
27
Last Close Price
504.82USD
Average target price
666.46USD
Spread / Average Target
+32.02%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















